nodes	percent_of_prediction	percent_of_DWPC	metapath
Amcinonide—ANXA1—stomach cancer	0.853	1	CbGaD
Amcinonide—ANXA1—gall bladder—stomach cancer	0.00636	0.155	CbGeAlD
Amcinonide—ANXA1—hematopoietic system—stomach cancer	0.0036	0.0878	CbGeAlD
Amcinonide—ANXA1—epithelium—stomach cancer	0.00329	0.0803	CbGeAlD
Amcinonide—ANXA1—smooth muscle tissue—stomach cancer	0.00317	0.0774	CbGeAlD
Amcinonide—ANXA1—pancreas—stomach cancer	0.00293	0.0715	CbGeAlD
Amcinonide—ANXA1—lymphoid tissue—stomach cancer	0.00254	0.0618	CbGeAlD
Amcinonide—ANXA1—digestive system—stomach cancer	0.0025	0.0611	CbGeAlD
Amcinonide—ANXA1—bone marrow—stomach cancer	0.00231	0.0563	CbGeAlD
Amcinonide—Telangiectasia—Fluorouracil—stomach cancer	0.00217	0.117	CcSEcCtD
Amcinonide—ANXA1—endocrine gland—stomach cancer	0.00207	0.0505	CbGeAlD
Amcinonide—ANXA1—liver—stomach cancer	0.00187	0.0455	CbGeAlD
Amcinonide—Stinging—Mitomycin—stomach cancer	0.00152	0.0819	CcSEcCtD
Amcinonide—Allergic contact dermatitis—Fluorouracil—stomach cancer	0.00146	0.079	CcSEcCtD
Amcinonide—ANXA1—lymph node—stomach cancer	0.00143	0.0349	CbGeAlD
Amcinonide—NR3C1—hematopoietic system—stomach cancer	0.00125	0.0305	CbGeAlD
Amcinonide—NR3C1—epithelium—stomach cancer	0.00114	0.0279	CbGeAlD
Amcinonide—Telangiectasia—Methotrexate—stomach cancer	0.00113	0.0609	CcSEcCtD
Amcinonide—NR3C1—smooth muscle tissue—stomach cancer	0.0011	0.0269	CbGeAlD
Amcinonide—NR3C1—pancreas—stomach cancer	0.00102	0.0248	CbGeAlD
Amcinonide—NR3C1—lymphoid tissue—stomach cancer	0.000881	0.0215	CbGeAlD
Amcinonide—NR3C1—digestive system—stomach cancer	0.00087	0.0212	CbGeAlD
Amcinonide—Secondary infection—Epirubicin—stomach cancer	0.000847	0.0457	CcSEcCtD
Amcinonide—NR3C1—bone marrow—stomach cancer	0.000802	0.0196	CbGeAlD
Amcinonide—Secondary infection—Doxorubicin—stomach cancer	0.000784	0.0423	CcSEcCtD
Amcinonide—NR3C1—endocrine gland—stomach cancer	0.000719	0.0175	CbGeAlD
Amcinonide—NR3C1—liver—stomach cancer	0.000648	0.0158	CbGeAlD
Amcinonide—Stinging—Fluorouracil—stomach cancer	0.000631	0.0341	CcSEcCtD
Amcinonide—Leukoderma—Methotrexate—stomach cancer	0.000626	0.0338	CcSEcCtD
Amcinonide—Tenderness—Fluorouracil—stomach cancer	0.000586	0.0316	CcSEcCtD
Amcinonide—Leukoderma—Epirubicin—stomach cancer	0.000586	0.0316	CcSEcCtD
Amcinonide—Infection—Floxuridine—stomach cancer	0.000556	0.03	CcSEcCtD
Amcinonide—Leukoderma—Doxorubicin—stomach cancer	0.000542	0.0293	CcSEcCtD
Amcinonide—Dermatitis contact—Fluorouracil—stomach cancer	0.000506	0.0273	CcSEcCtD
Amcinonide—NR3C1—lymph node—stomach cancer	0.000497	0.0121	CbGeAlD
Amcinonide—Folliculitis—Methotrexate—stomach cancer	0.000423	0.0228	CcSEcCtD
Amcinonide—Folliculitis—Epirubicin—stomach cancer	0.000396	0.0214	CcSEcCtD
Amcinonide—Pain—Mitomycin—stomach cancer	0.000375	0.0202	CcSEcCtD
Amcinonide—Folliculitis—Doxorubicin—stomach cancer	0.000367	0.0198	CcSEcCtD
Amcinonide—Dermatitis—Floxuridine—stomach cancer	0.000352	0.019	CcSEcCtD
Amcinonide—Rash pustular—Epirubicin—stomach cancer	0.000312	0.0169	CcSEcCtD
Amcinonide—Stinging—Epirubicin—stomach cancer	0.000307	0.0166	CcSEcCtD
Amcinonide—Rash pustular—Doxorubicin—stomach cancer	0.000289	0.0156	CcSEcCtD
Amcinonide—Dexamethasone—ANXA1—stomach cancer	0.000287	0.367	CrCbGaD
Amcinonide—Stinging—Doxorubicin—stomach cancer	0.000284	0.0153	CcSEcCtD
Amcinonide—Dermatitis—Mitomycin—stomach cancer	0.000276	0.0149	CcSEcCtD
Amcinonide—Dermatitis contact—Epirubicin—stomach cancer	0.000246	0.0133	CcSEcCtD
Amcinonide—ANXA1—GPCR ligand binding—F2R—stomach cancer	0.000245	0.00281	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—CDKN1B—stomach cancer	0.000244	0.0028	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—HRH4—stomach cancer	0.000241	0.00276	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—IL1B—stomach cancer	0.00024	0.00275	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—RORA—stomach cancer	0.000239	0.00275	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—HTR1A—stomach cancer	0.000238	0.00273	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—ZNF160—stomach cancer	0.000238	0.00273	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—ADRB2—stomach cancer	0.000237	0.00272	CbGpPWpGaD
Amcinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—stomach cancer	0.000236	0.00271	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—RUNX3—stomach cancer	0.000234	0.00269	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—CCND1—stomach cancer	0.000233	0.00267	CbGpPWpGaD
Amcinonide—NR3C1—Endoderm Differentiation—SMAD4—stomach cancer	0.000231	0.00265	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—APC—stomach cancer	0.000231	0.00265	CbGpPWpGaD
Amcinonide—Dermatitis contact—Doxorubicin—stomach cancer	0.000228	0.0123	CcSEcCtD
Amcinonide—ANXA1—Spinal Cord Injury—MMP9—stomach cancer	0.000226	0.00259	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—ADRB1—stomach cancer	0.000223	0.00256	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—HSPD1—stomach cancer	0.00022	0.00252	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IL10—stomach cancer	0.000219	0.00252	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HRH4—stomach cancer	0.000219	0.00251	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—stomach cancer	0.000219	0.00251	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	0.000215	0.00247	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—KISS1—stomach cancer	0.000215	0.00246	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—stomach cancer	0.000211	0.00242	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—BMP2—stomach cancer	0.000205	0.00235	CbGpPWpGaD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—stomach cancer	0.000205	0.00235	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptor transcription pathway—PPARG—stomach cancer	0.000203	0.00232	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD4—stomach cancer	0.000201	0.00231	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—stomach cancer	0.000195	0.00224	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—stomach cancer	0.000195	0.00224	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—KISS1—stomach cancer	0.000195	0.00224	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—MAPK3—stomach cancer	0.000192	0.0022	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—CCND1—stomach cancer	0.000191	0.00219	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—JUN—stomach cancer	0.000191	0.00219	CbGpPWpGaD
Amcinonide—Infection—Irinotecan—stomach cancer	0.000189	0.0102	CcSEcCtD
Amcinonide—ANXA1—Spinal Cord Injury—MYC—stomach cancer	0.000187	0.00214	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—GAST—stomach cancer	0.000185	0.00212	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—RGS2—stomach cancer	0.000185	0.00212	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—GADD45A—stomach cancer	0.000184	0.00211	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—PLAU—stomach cancer	0.000183	0.0021	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—MAPK1—stomach cancer	0.000183	0.0021	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—EGFR—stomach cancer	0.000183	0.0021	CbGpPWpGaD
Amcinonide—Infection—Fluorouracil—stomach cancer	0.000181	0.00978	CcSEcCtD
Amcinonide—ANXA1—GPCR ligand binding—ADRB2—stomach cancer	0.000181	0.00207	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	0.000179	0.00206	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GLI3—stomach cancer	0.000179	0.00205	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—KISS1R—stomach cancer	0.000179	0.00205	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	0.000175	0.00201	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TNF—stomach cancer	0.000174	0.002	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—HTR1A—stomach cancer	0.000173	0.00198	CbGpPWpGaD
Amcinonide—NR3C1—Circadian Clock—SERPINE1—stomach cancer	0.000172	0.00197	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—CXCL8—stomach cancer	0.000171	0.00196	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—RBP1—stomach cancer	0.00017	0.00196	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—stomach cancer	0.00017	0.00195	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—RGS2—stomach cancer	0.000168	0.00192	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—GAST—stomach cancer	0.000168	0.00192	CbGpPWpGaD
Amcinonide—NR3C1—Endoderm Differentiation—APC—stomach cancer	0.000167	0.00191	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—VEGFA—stomach cancer	0.000167	0.00191	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	0.000166	0.00191	CbGpPWpGaD
Amcinonide—Pain—Irinotecan—stomach cancer	0.000163	0.00879	CcSEcCtD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL1RN—stomach cancer	0.000161	0.00185	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	0.000158	0.00182	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	0.000158	0.00181	CbGpPWpGaD
Amcinonide—Pain—Fluorouracil—stomach cancer	0.000156	0.00842	CcSEcCtD
Amcinonide—Prednisolone—CYP2A6—stomach cancer	0.000154	0.198	CrCbGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—stomach cancer	0.000154	0.00177	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TP53—stomach cancer	0.000153	0.00176	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—MYC—stomach cancer	0.000153	0.00176	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	0.000153	0.00176	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—ZNF559—stomach cancer	0.000151	0.00174	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—MAPK1—stomach cancer	0.00015	0.00172	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—EGFR—stomach cancer	0.00015	0.00172	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	0.00015	0.00172	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—CXCL8—stomach cancer	0.000144	0.00165	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—KRAS—stomach cancer	0.000142	0.00163	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—IL6—stomach cancer	0.00014	0.00161	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—AGTR2—stomach cancer	0.00014	0.00161	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—JUN—stomach cancer	0.000139	0.0016	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—WWOX—stomach cancer	0.000139	0.00159	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—F2R—stomach cancer	0.000138	0.00159	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	0.000138	0.00158	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—HTR1A—stomach cancer	0.000135	0.00155	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CDKN2A—stomach cancer	0.000132	0.00152	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—MAPK8—stomach cancer	0.000132	0.00151	CbGpPWpGaD
Amcinonide—Infection—Docetaxel—stomach cancer	0.000131	0.00706	CcSEcCtD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	0.000131	0.0015	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HRH4—stomach cancer	0.000129	0.00148	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—WIF1—stomach cancer	0.000129	0.00148	CbGpPWpGaD
Amcinonide—Pruritus—Fluorouracil—stomach cancer	0.000129	0.00697	CcSEcCtD
Amcinonide—NR3C1—Gene Expression—PRPF19—stomach cancer	0.000129	0.00148	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	0.000127	0.00146	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AGTR2—stomach cancer	0.000127	0.00146	CbGpPWpGaD
Amcinonide—Infection—Capecitabine—stomach cancer	0.000127	0.00684	CcSEcCtD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—stomach cancer	0.000126	0.00145	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—ADRB1—stomach cancer	0.000126	0.00145	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—TP53—stomach cancer	0.000126	0.00145	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—F2R—stomach cancer	0.000126	0.00144	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—RXRB—stomach cancer	0.000125	0.00144	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	0.000124	0.00143	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	0.000124	0.00143	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HTR1A—stomach cancer	0.000122	0.0014	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—BDNF—stomach cancer	0.000121	0.00139	CbGpPWpGaD
Amcinonide—Dermatitis—Irinotecan—stomach cancer	0.00012	0.00648	CcSEcCtD
Amcinonide—NR3C1—AP-1 transcription factor network—CXCL8—stomach cancer	0.00012	0.00138	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PRKAB1—stomach cancer	0.000119	0.00137	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—stomach cancer	0.000119	0.00136	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	0.000118	0.00136	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	0.000117	0.00135	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CDKN1B—stomach cancer	0.000117	0.00134	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL10—stomach cancer	0.000116	0.00133	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—RNF43—stomach cancer	0.000115	0.00132	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—KISS1—stomach cancer	0.000115	0.00132	CbGpPWpGaD
Amcinonide—Dermatitis—Fluorouracil—stomach cancer	0.000115	0.0062	CcSEcCtD
Amcinonide—NR3C1—Gene Expression—ZNF160—stomach cancer	0.000115	0.00132	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	0.000115	0.00131	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—ADRB1—stomach cancer	0.000114	0.00131	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—stomach cancer	0.000113	0.0013	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—stomach cancer	0.000113	0.0013	CbGpPWpGaD
Amcinonide—Pain—Docetaxel—stomach cancer	0.000113	0.00608	CcSEcCtD
Amcinonide—NR3C1—Adipogenesis—IRS2—stomach cancer	0.000112	0.00129	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CCND1—stomach cancer	0.000112	0.00128	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—JUN—stomach cancer	0.000111	0.00128	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—PIK3CA—stomach cancer	0.00011	0.00126	CbGpPWpGaD
Amcinonide—Pain—Capecitabine—stomach cancer	0.000109	0.00589	CcSEcCtD
Amcinonide—NR3C1—AP-1 transcription factor network—MMP9—stomach cancer	0.000108	0.00125	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	0.000108	0.00124	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—stomach cancer	0.000107	0.00123	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—stomach cancer	0.000106	0.00121	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—EEF1A2—stomach cancer	0.000105	0.0012	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	0.000104	0.0012	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—IL6ST—stomach cancer	0.000103	0.00119	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FST—stomach cancer	0.000103	0.00118	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—ADRB2—stomach cancer	0.000102	0.00117	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—RORA—stomach cancer	0.000101	0.00116	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HBEGF—stomach cancer	0.0001	0.00115	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—stomach cancer	9.92e-05	0.00114	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—GAST—stomach cancer	9.9e-05	0.00114	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—RGS2—stomach cancer	9.9e-05	0.00114	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—JUN—stomach cancer	9.82e-05	0.00113	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—stomach cancer	9.81e-05	0.00113	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—stomach cancer	9.62e-05	0.0011	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—PPARG—stomach cancer	9.58e-05	0.0011	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—stomach cancer	9.52e-05	0.00109	CbGpPWpGaD
Amcinonide—Infection—Methotrexate—stomach cancer	9.43e-05	0.00509	CcSEcCtD
Amcinonide—ANXA1—Signaling Pathways—FGG—stomach cancer	9.38e-05	0.00108	CbGpPWpGaD
Amcinonide—Pruritus—Docetaxel—stomach cancer	9.32e-05	0.00503	CcSEcCtD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—stomach cancer	9.3e-05	0.00107	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—ADRB2—stomach cancer	9.27e-05	0.00106	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PPP2R1A—stomach cancer	9.08e-05	0.00104	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	9.08e-05	0.00104	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—RARB—stomach cancer	9.04e-05	0.00104	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PRKAA1—stomach cancer	9.03e-05	0.00104	CbGpPWpGaD
Amcinonide—Pruritus—Capecitabine—stomach cancer	9.02e-05	0.00487	CcSEcCtD
Amcinonide—NR3C1—AP-1 transcription factor network—MYC—stomach cancer	8.96e-05	0.00103	CbGpPWpGaD
Amcinonide—Infection—Epirubicin—stomach cancer	8.83e-05	0.00476	CcSEcCtD
Amcinonide—Dexamethasone—CYP2A6—stomach cancer	8.8e-05	0.113	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—RBP4—stomach cancer	8.72e-05	0.001	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CXCL8—stomach cancer	8.72e-05	0.001	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	8.69e-05	0.000997	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—HNRNPL—stomach cancer	8.68e-05	0.000997	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—SERPINE1—stomach cancer	8.63e-05	0.000991	CbGpPWpGaD
Amcinonide—Dermatitis—Docetaxel—stomach cancer	8.3e-05	0.00448	CcSEcCtD
Amcinonide—NR3C1—Gene Expression—EEF1A1—stomach cancer	8.28e-05	0.000951	CbGpPWpGaD
Amcinonide—Infection—Doxorubicin—stomach cancer	8.17e-05	0.00441	CcSEcCtD
Amcinonide—Pain—Methotrexate—stomach cancer	8.12e-05	0.00438	CcSEcCtD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—stomach cancer	8.12e-05	0.000932	CbGpPWpGaD
Amcinonide—Triamcinolone—PTGS2—stomach cancer	8.08e-05	0.104	CrCbGaD
Amcinonide—Dermatitis—Capecitabine—stomach cancer	8.03e-05	0.00434	CcSEcCtD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—stomach cancer	7.97e-05	0.000915	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL6R—stomach cancer	7.97e-05	0.000914	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—stomach cancer	7.72e-05	0.000887	CbGpPWpGaD
Amcinonide—Pain—Epirubicin—stomach cancer	7.6e-05	0.0041	CcSEcCtD
Amcinonide—ANXA1—Signaling Pathways—HSPB1—stomach cancer	7.5e-05	0.000861	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AGTR2—stomach cancer	7.5e-05	0.000861	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—F2R—stomach cancer	7.42e-05	0.000852	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—BMP2—stomach cancer	7.42e-05	0.000852	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—TP53—stomach cancer	7.36e-05	0.000845	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AKR1C3—stomach cancer	7.3e-05	0.000838	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HTR1A—stomach cancer	7.22e-05	0.000829	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—EXOSC5—stomach cancer	7.15e-05	0.000821	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—CPSF1—stomach cancer	7.15e-05	0.000821	CbGpPWpGaD
Amcinonide—Pain—Doxorubicin—stomach cancer	7.03e-05	0.00379	CcSEcCtD
Amcinonide—ANXA1—GPCR downstream signaling—PRKCB—stomach cancer	6.99e-05	0.000803	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—POLR3K—stomach cancer	6.94e-05	0.000797	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ADRB1—stomach cancer	6.76e-05	0.000775	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IL6—stomach cancer	6.74e-05	0.000773	CbGpPWpGaD
Amcinonide—Pruritus—Methotrexate—stomach cancer	6.72e-05	0.00362	CcSEcCtD
Amcinonide—Betamethasone—PTGS2—stomach cancer	6.62e-05	0.0849	CrCbGaD
Amcinonide—NR3C1—Adipogenesis—CDKN1A—stomach cancer	6.59e-05	0.000756	CbGpPWpGaD
Amcinonide—Prednisone—ALB—stomach cancer	6.53e-05	0.0837	CrCbGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—stomach cancer	6.48e-05	0.000744	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—RPS6—stomach cancer	6.45e-05	0.000741	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PRKCB—stomach cancer	6.35e-05	0.000729	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—IL6ST—stomach cancer	6.32e-05	0.000726	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—stomach cancer	6.32e-05	0.000725	CbGpPWpGaD
Amcinonide—Pruritus—Epirubicin—stomach cancer	6.29e-05	0.00339	CcSEcCtD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL1B—stomach cancer	6.06e-05	0.000696	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—RXRB—stomach cancer	6.02e-05	0.000691	CbGpPWpGaD
Amcinonide—Dermatitis—Methotrexate—stomach cancer	5.98e-05	0.00323	CcSEcCtD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—stomach cancer	5.94e-05	0.000681	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HBEGF—stomach cancer	5.93e-05	0.000681	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—RPL13—stomach cancer	5.9e-05	0.000678	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—RPL18—stomach cancer	5.9e-05	0.000678	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—STAT3—stomach cancer	5.88e-05	0.000675	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—JUN—stomach cancer	5.87e-05	0.000674	CbGpPWpGaD
Amcinonide—Pruritus—Doxorubicin—stomach cancer	5.82e-05	0.00314	CcSEcCtD
Amcinonide—ANXA1—Signaling by GPCR—IL6R—stomach cancer	5.64e-05	0.000648	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—RHOA—stomach cancer	5.61e-05	0.000644	CbGpPWpGaD
Amcinonide—Dermatitis—Epirubicin—stomach cancer	5.6e-05	0.00302	CcSEcCtD
Amcinonide—NR3C1—Gene Expression—RPS15—stomach cancer	5.51e-05	0.000632	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—RPS21—stomach cancer	5.51e-05	0.000632	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ADRB2—stomach cancer	5.47e-05	0.000628	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—SNRPB—stomach cancer	5.42e-05	0.000622	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PPP2R1A—stomach cancer	5.36e-05	0.000616	CbGpPWpGaD
Amcinonide—Dermatitis—Doxorubicin—stomach cancer	5.18e-05	0.00279	CcSEcCtD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—stomach cancer	5.13e-05	0.000589	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—RHOA—stomach cancer	5.1e-05	0.000585	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—TNF—stomach cancer	5.09e-05	0.000584	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—SMAD4—stomach cancer	5.03e-05	0.000577	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SMAD4—stomach cancer	4.98e-05	0.000572	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CXCL8—stomach cancer	4.93e-05	0.000566	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—RORA—stomach cancer	4.87e-05	0.000559	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FYN—stomach cancer	4.73e-05	0.000543	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—DNMT3B—stomach cancer	4.56e-05	0.000524	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CXCL8—stomach cancer	4.47e-05	0.000514	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—RPL15—stomach cancer	4.47e-05	0.000514	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FGFR2—stomach cancer	4.44e-05	0.00051	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—TNF—stomach cancer	4.4e-05	0.000505	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—RARB—stomach cancer	4.35e-05	0.0005	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—RPS26—stomach cancer	4.17e-05	0.000479	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—IL6—stomach cancer	4.11e-05	0.000471	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IRS2—stomach cancer	4.06e-05	0.000467	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CAV1—stomach cancer	3.94e-05	0.000452	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—APOA1—stomach cancer	3.93e-05	0.000451	CbGpPWpGaD
Amcinonide—Dexamethasone—PTGS2—stomach cancer	3.85e-05	0.0494	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—PRKCB—stomach cancer	3.75e-05	0.000431	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IL6ST—stomach cancer	3.74e-05	0.000429	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—HSPB1—stomach cancer	3.65e-05	0.000419	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—APC—stomach cancer	3.59e-05	0.000412	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL6—stomach cancer	3.55e-05	0.000407	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—RPS19—stomach cancer	3.55e-05	0.000407	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—PPARG—stomach cancer	3.5e-05	0.000402	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—MAPK3—stomach cancer	3.44e-05	0.000395	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—DNMT1—stomach cancer	3.39e-05	0.000389	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—HSPA8—stomach cancer	3.34e-05	0.000384	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IL6R—stomach cancer	3.33e-05	0.000383	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—MAPK1—stomach cancer	3.27e-05	0.000376	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—EGFR—stomach cancer	3.27e-05	0.000375	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—SERPINE1—stomach cancer	3.15e-05	0.000362	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—RPS6—stomach cancer	3.14e-05	0.00036	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—PIK3CA—stomach cancer	3.13e-05	0.000359	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SERPINE1—stomach cancer	3.12e-05	0.000358	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—KRAS—stomach cancer	3.09e-05	0.000355	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—RHOA—stomach cancer	3.01e-05	0.000346	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NOS3—stomach cancer	2.98e-05	0.000342	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—PIK3CA—stomach cancer	2.84e-05	0.000326	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ERBB2—stomach cancer	2.79e-05	0.00032	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CXCL8—stomach cancer	2.64e-05	0.000303	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HRAS—stomach cancer	2.63e-05	0.000301	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—PPP2R1A—stomach cancer	2.61e-05	0.000299	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CDKN1B—stomach cancer	2.58e-05	0.000296	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—IL6—stomach cancer	2.51e-05	0.000289	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCND1—stomach cancer	2.46e-05	0.000283	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—JUN—stomach cancer	2.46e-05	0.000282	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—SMAD4—stomach cancer	2.42e-05	0.000278	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MMP9—stomach cancer	2.39e-05	0.000274	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CDKN1A—stomach cancer	2.38e-05	0.000273	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MAPK8—stomach cancer	2.33e-05	0.000267	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—ERCC2—stomach cancer	2.21e-05	0.000254	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—VEGFA—stomach cancer	2.15e-05	0.000246	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—STAT3—stomach cancer	2.13e-05	0.000244	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MAPK3—stomach cancer	2.03e-05	0.000233	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—MYC—stomach cancer	1.99e-05	0.000229	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MYC—stomach cancer	1.98e-05	0.000227	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MAPK1—stomach cancer	1.93e-05	0.000222	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—EGFR—stomach cancer	1.93e-05	0.000222	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—KRAS—stomach cancer	1.83e-05	0.00021	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—PPARG—stomach cancer	1.68e-05	0.000193	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PIK3CA—stomach cancer	1.68e-05	0.000192	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TP53—stomach cancer	1.62e-05	0.000186	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HRAS—stomach cancer	1.55e-05	0.000178	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—SERPINE1—stomach cancer	1.52e-05	0.000174	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IL6—stomach cancer	1.48e-05	0.00017	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—MAPK3—stomach cancer	9.87e-06	0.000113	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—MYC—stomach cancer	9.6e-06	0.00011	CbGpPWpGaD
